Switch to:
GuruFocus has detected 1 Warning Sign with Cascadian Therapeutics Inc $CASC.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
Cascadian Therapeutics Inc (NAS:CASC)
EV-to-EBITDA
-1.47 (As of Today)

EV/EBITDA ratio is calculated as enterprise value divided by its EBITDA. As of today, Cascadian Therapeutics Inc's enterprise value is $92.23 Mil. Cascadian Therapeutics Inc's earnings before depreciation and amortization for the trailing twelve months (TTM) ended in Mar. 2017 was $-62.77 Mil. Therefore, Cascadian Therapeutics Inc's EV/EBITDA ratio for today is -1.47.

CASC' s EV-to-EBITDA Range Over the Past 10 Years
Min: -8605.4   Max: 9.8
Current: -1.46

-8605.4
9.8

During the past 13 years, the highest EV/EBITDA Ratio of Cascadian Therapeutics Inc was 9.80. The lowest was -8605.40. And the median was -1.80.

CASC's EV-to-EBITDA is ranked lower than
99.99% of the 466 Companies
in the Global Biotechnology industry.

( Industry Median: 17.12 vs. CASC: -1.46 )

EV/EBITDA (Enterprise value/EBITDA) is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the P/E Ratio to determine the fair market value of a company.

As of today, Cascadian Therapeutics Inc's stock price is $4.43. Cascadian Therapeutics Inc's earnings per share for the trailing twelve months (TTM) ended in Mar. 2017 was $-2.77. Therefore, Cascadian Therapeutics Inc's P/E Ratio for today is .

The "classic" EV/EBITDA ratio is much better in capturing debt and net cash than the P/E Ratio.


Definition

Cascadian Therapeutics Inc's EV/EBITDA for today is calculated as:

EV/EBITDA=Enterprise Value (Today)/Earnings Before Depreciation and Amortization (TTM)
=92.231/-62.769
=-1.47

Cascadian Therapeutics Inc's current Enterprise Value is $92.23 Mil.
Cascadian Therapeutics Inc's Earnings Before Depreciation and Amortization for the trailing twelve months (TTM) ended in Mar. 2017 was -30.32 (Jun. 2016 ) + -10.635 (Sep. 2016 ) + -10.431 (Dec. 2016 ) + -11.383 (Mar. 2017 ) = $-62.77 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.


Explanation

EV/EBITDA (Enterprise value/EBITDA) is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the P/E Ratio to determine the fair market value of a company.

Cascadian Therapeutics Inc's P/E Ratio for today is calculated as:

P/E Ratio=Share Price (Today)/Earnings Per Share (TTM)
=4.43/-2.77
=

Cascadian Therapeutics Inc's share price for today is $4.43.
Cascadian Therapeutics Inc's Earnings Per Share for the trailing twelve months (TTM) ended in Mar. 2017 was -1.56 (Jun. 2016 ) + -0.54 (Sep. 2016 ) + -0.37 (Dec. 2016 ) + -0.3 (Mar. 2017 ) = $-2.77.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

Study has found that the companies with the lowest EV/EBITDA outperforms companies measured as cheap by other ratios such as P/E Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Related Terms

Enterprise Value, Earnings Before Depreciation and Amortization, P/E Ratio


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

Cascadian Therapeutics Inc Annual Data

Dec07Dec08Dec09Dec10Dec11Dec12Dec13Dec14Dec15Dec16
ev2ebitda -1.04-0.43-6.31-3.40-6.53-11.08-1.58-2.31-4.80-0.54

Cascadian Therapeutics Inc Quarterly Data

Dec14Mar15Jun15Sep15Dec15Mar16Jun16Sep16Dec16Mar17
ev2ebitda -2.31-1.81-5.51-3.86-4.80-2.00-0.79-2.39-0.540.00
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

FEEDBACK